Tag Archives: vital

SAG-AFTRA says that interim agreements are “a vital part” of its plan to weather Hollywood’s labor strike – The Verge

  1. SAG-AFTRA says that interim agreements are “a vital part” of its plan to weather Hollywood’s labor strike The Verge
  2. “It’s Scabbing”: Sarah Silverman Spoke Out Against Actors Who Are Still Working During The SAG-AFTRA Strike Yahoo Entertainment
  3. SAG-AFTRA Insists Waivers for Indies Will Put More Pressure on AMPTP to Negotiate IndieWire
  4. Sarah Silverman bashes Anne Hathway, Paul Rudd, other stars for making indie movies Geo News
  5. Sarah Silverman Softens Strike Waivers Stance After Chat With Fran Drescher: ‘We All Want the Same Thing’ (Video) Yahoo Entertainment
  6. View Full Coverage on Google News

Read original article here

SAG-AFTRA Defends Indie Productions as ‘Vital’ Part of Strike Strategy – Variety

  1. SAG-AFTRA Defends Indie Productions as ‘Vital’ Part of Strike Strategy Variety
  2. “It’s Scabbing”: Sarah Silverman Spoke Out Against Actors Who Are Still Working During The SAG-AFTRA Strike Yahoo Entertainment
  3. Sarah Silverman Slams Working Actors During Strike BuzzFeed
  4. Sarah Silverman bashes Anne Hathway, Paul Rudd, other stars for making indie movies Geo News
  5. Sarah Silverman Softens Strike Waivers Stance After Chat With Fran Drescher: ‘We All Want the Same Thing’ (Video) Yahoo Entertainment
  6. View Full Coverage on Google News

Read original article here

Cillian Murphy Says Oppenheimer Sex Scenes With Florence Pugh Were ‘Vital’ to the Plot – IGN

  1. Cillian Murphy Says Oppenheimer Sex Scenes With Florence Pugh Were ‘Vital’ to the Plot IGN
  2. Why the Sex Scenes in Oppenheimer are So Fascinating Pajiba Entertainment News
  3. Cillian Murphy Says Divisive ‘Oppenheimer’ Sex Scene Is ‘Vital’; Oppenheimer’s Grandson ‘Would’ve Removed’ That Poison Apple Moment Yahoo Entertainment
  4. Why Oppenheimer controversy is a misplaced outrage over Bhagavad Gita Firstpost
  5. “That’s the most awkward possible part of our job”: Cillian Murphy Admits He Did Not Like Doing the S*x Scene With Florence Pugh in ‘Oppenheimer’ FandomWire
  6. View Full Coverage on Google News

Read original article here

Cillian Murphy Says Divisive ‘Oppenheimer’ Sex Scene Is ‘Vital’; Oppenheimer’s Grandson ‘Would’ve Removed’ That Poison Apple Moment – Variety

  1. Cillian Murphy Says Divisive ‘Oppenheimer’ Sex Scene Is ‘Vital’; Oppenheimer’s Grandson ‘Would’ve Removed’ That Poison Apple Moment Variety
  2. Why the Sex Scenes in Oppenheimer are So Fascinating Pajiba Entertainment News
  3. Oppenheimer sex scene: Other books to read during intercourse, recommended by experts. Slate
  4. Javed Akhtar calls Oppenheimer a ‘great film,’ leaves a snarky reply for a user who asked ‘Explain isotope’: ‘This is not necessary..’ The Indian Express
  5. View Full Coverage on Google News

Read original article here

Russian missiles strike vital infrastructure in Kyiv and Kharkiv

KYIV, Jan 14 (Reuters) – Russian missile attacks hit critical infrastructure in Kyiv and the eastern city of Kharkiv on Saturday morning, and the governor of another region warned that a massive missile strike could follow in the coming hours.

Reuters journalists heard a series of blasts in Kyiv before the air raid siren even sounded, which is highly unusual. No one was reported hurt, but missile debris caused a fire in one place and houses were damaged outside the capital, officials said.

“Explosions in the (eastern) Dniprovskiy district. All agencies heading to the site. Stay in your shelters!” Kyiv Mayor Vitali Klitschko wrote on the Telegram messaging app.

Russia, which invaded last February, has been pounding Ukraine’s energy infrastructure with missiles and drones since October, causing sweeping blackouts and disruptions to central heating and running water as winter bites.

“An infrastructure facility was hit. No critical damage or fire. All emergency services are working at the site. No one is wounded,” Kyiv’s military administration said in a statement.

Ukrenergo, which runs the power grid, said its workers were racing to fix the damage and that the network was grappling with a power deficit caused by earlier attacks even though it was -2 Celsius (28 Fahrenheit) in Kyiv, only mildly cold.

Kyiv’s mayor said the debris of a missile came down on a non-residential area in the Holosiivskiy district in the west of Kyiv, causing a fire but hurting no one.

Residential infrastructure was also hit in the village of Kopyliv in the region just outside the capital. The windows and roofs of 18 privately owned houses were shattered or damaged by the blast, Oleksiy Kuleba, the regional governor, said.

Air Force spokesperson Yuriy Ihnat said Russia’s missiles had likely been fired along a high, looping ballistic trajectory from the north, which would explain why the air raid siren did not sound.

Ukraine is not able to identify and shoot down ballistic missiles, he told the Ukrainska Pravda online outlet.

MISSILES STRIKE KHARKIV

In Ukraine’s northeast, Oleg Synehubov, Kharkiv’s regional governor, said two S-300 missiles struck the city near the Russian border early on Saturday.

The attacks hit critical energy infrastructure and industrial facilities in the Kharkiv and Chuhuev district of the region, he said.

“Our emergency services units and energy workers are working to liquidate the consequences and stabilise the situation with energy supplies,” he said.

The governor of the central Cherkasy region warned that a massive Russian missile strike could follow later on Saturday, while the governor of Mykolaiv to the south said that 17 Russian Tupolev warplanes had taken off from their air bases.

But after their statements the air raid alarm in Kyiv and the surrounding region was lifted.

The strikes on Saturday came as Ukrainian and Russian forces battled for control of Soledar, a small salt-mining town in eastern Ukraine that for days has been the focus of a relentless Russian assault.

Russia said on Friday that its forces had taken control of Soledar, in what would be a rare success for Moscow after months of battlefield reverses, but Kyiv said its troops were still fighting in the town.

Reuters could not immediately verify the situation in Soledar.

Writing by Tom Balmforth
Editing by Angus MacSwan, Mark Heinrich and Frances Kerry

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

Victor Chang Cardiac Research: Experts reveal vital heart health tips

Heart health experts have revealed the three lifestyle changes that could save your life if taken on board in 2023 – including getting checked for a ‘new’ type of cholesterol.

Australians are urged to get more sleep, swap regular salt for potassium-enriched salt, and consider undergoing a blood test for a new ‘bad’ cholesterol marker.

The vital advice could prevent the development of heart disease, which is currently the leading cause of death in Australia.

Experts from the Victor Chang Cardiac Research Institute say the life saving tips are easy to follow, research suggests lifestyle changes can reduce the risk of heart disease by 50 per cent. 

Heart health experts have revealed the three lifestyle changes that could save your life if taken on board in 2023

Australians are urged to get more sleep, swap regular salt for potassium-enriched salt (left), and consider undergoing a blood test for a new ‘bad’ cholesterol marker. Cholesterol can be caused by genetics, poor diet, smoking, obesity and lack of exercise

Getting a good night’s sleep

New research indicates adults need at least seven to nine hours of sleep a night to keep their hearts healthy, however, approximately a third of all Australians do not get enough sleep.

The American Heart Association has just added healthy sleep as an essential tool for maintaining good heart health, along with not smoking, exercising, and a healthy diet. 

‘The evidence is very clear – poor sleep health is linked to heart disease,’ Professor Jason Kovacic of the Victor Chang Institute said.

‘A lack of sleep (less than 7 hours), or too much sleep (more than 9 hours for healthy adults), raises the risk of obesity, high blood pressure, diabetes, and cardiovascular disease.’ 

The American Heart Association’s essential eight tips for heart health include healthy sleep, not smoking, exercising, and a healthy diet

Swap the salt

Experts recommend replacing regular salt for potassium-enriched salt which can be bought in Coles and Woolworths for about $3

Experts recommend replacing regular salt for potassium-enriched salt, as potassium has a significant effect on reducing blood pressure. 

A study by The George Institute for Global Health demonstrated a significant reduction in rates of stroke, heart attack, and death in people who replaced their regular table salt with a reduced-sodium, added-potassium “salt substitute”.

‘This simple switch really could make a difference to our heart health,’ Professor Kovacic said.

‘While most of the salt we eat is already in the foods we buy, any change we can make at home to our everyday cooking could help keep our blood pressure in a healthy range.’

The cardiologist believes this is one of the easiest changes to make as ‘there is no discernible taste difference’ between the salts.

It’s recommended people speak to their doctor before switching salts as high potassium levels can be dangerous for people with kidney problems or for those that are on certain high blood pressure medications.

A new marker of ‘bad’ cholesterol

Experts have always warned against a bad type of cholesterol called LDL, but there is another type we should also have on our radar called Lipoprotein(a). 

Lipoprotein(a) is more associated with genetics rather than lifestyle choices, and is now known to be a cause of atherosclerosis – a major source of heart disease.

High levels of the cholesterol can be picked up in a blood test ordered by your GP and should be undertaken by anyone with a family history of heart disease or by anyone who has had heart disease or stroke at an earlier age than normal.

‘This is not a test everyone should be having but if you suspect heart disease runs in your family, or if you are a male below 55 or a woman below 60 with cardiovascular disease then this test can determine if Lp(a) might be part of the cause,’ Professor Kovacic said.

Experts have always warned against a bad type of cholesterol called LDL, but there is another type we should also have on our radar called Lipoprotein(a)

Three ways to protect your heart health in 2023:

1.  Get at least seven to nine hours of sleep a night.

2.  Replace regular salt for potassium-enriched salt, as potassium has a significant effect on reducing blood pressure.

3.  Get a blood tests for Lipoprotein(a) if you suspect heart disease runs in your family, or if you are a male below 55 or a woman below 60 with cardiovascular disease.

Source: Victor Chang Cardiac Research Institute

Read original article here

Dr. Sanjay Gupta: After two years of Covid-19 vaccines, here’s why they’re still vital



CNN
 — 

In the United States, approximately 658 million Covid-19 vaccine doses have been administered since they were first distributed exactly two years ago Wednesday.

Framing the significance of preventive measures like vaccines can be challenging, which is why a new report from the Commonwealth Fund and Yale School of Public Health made headlines: According to their modeling of disease transmission across all age demographics and taking into account the existing health conditions in so many Americans, Covid vaccines prevented an estimated 3.2 million deaths and 18.5 million hospitalizations from their introduction in December 2020 to November 30, 2022.

That is why it is surprising to hear, according to a Kaiser Family Foundation analysis of data from the US Centers for Disease Control and Prevention, that from April through August – the last month included in the analysis – there were more vaccinated than unvaccinated people dying of Covid. The vaccinated categories include people who were vaccinated with the primary series and people who had been vaccinated and received at least one non-bivalent booster.

According to a CNN analysis of additional CDC data for September, 12,593 people died of Covid. A CDC sample of the deaths found 39% were unvaccinated, and 61% were vaccinated.

This phenomenon has many people – especially vaccine skeptics, but even stalwart vaccine supporters – confused and wondering if Covid vaccines and boosters are still effective and warranted.

The short answer is yes – but understanding why requires a crash course in statistics. We enlisted the help of Jeffrey Morris, a professor and the director of the Division of Biostatistics at the Perelman School of Medicine at the University of Pennsylvania, who helped us define three key reasons more vaccinated than unvaccinated people are dying of Covid.

One of the main reasons we see more vaccinated than unvaccinated people dying of Covid is a basic one. At this point in time, there are simply many more people who are vaccinated.

Think of it like this: If we round the September deaths to 13,000 and use the CDC sampling percentages, approximately 7,800 were vaccinated and approximately 5,200 were unvaccinated. The conclusion might be that you are far more likely to die if you are vaccinated. And, mathematically that would be true based on the raw numbers alone. If you stopped your analysis at this point, you will have committed a statistical error known as a base rate fallacy.

If instead, you take the extra step of accounting for the total number of fully vaccinated adults 18 and older in the United States (around 203 million) versus the total number of unvaccinated adults (around 55 million), a very different picture emerges.

Among the vaccinated population, 7,800/203 million died in September, which equals a rate of 38 deaths for every 1 million people. For the unvaccinated population, 5,200/55 million died, which equals a rate of 95 deaths for every 1 million people. That means an adult who is unvaccinated is roughly 2.5 times more likely to die than one who is vaccinated.

“You have to take into account the size of those groups,” explained Morris, who also publishes a blog, COVID-19 Data Science, to “just communicate what the emerging data suggest.”

There is another important difference when looking at the vaccinated versus unvaccinated populations in the United States. The vaccinated population skews older and has more health conditions. These are the same groups that are much more likely to have worse outcomes, like hospitalization and death, when infected with SARS-CoV-2, the virus that causes Covid-19. For example, CDC data show more than 90% of deaths through mid-November have been in those 65 or older.

“So those things lead to a higher risk of death and also a higher probability of being vaccinated,” Morris said. “That’s the key: if the vaccine uptake of those high-risk groups is high enough, then we can have a majority of the hospitalized or fatal cases be higher in the vaccinated population.”

You are more likely to die if you are older, and also more likely to be vaccinated if you are older. It does not mean vaccination is more likely to lead to death.

So if age isn’t taken into account when assessing vaccine efficacy, it can lead to something known as Simpson’s paradox, where a trend can appear to be the opposite of reality.

Morris said those kinds of errors not only result in a serious underestimation of the benefit of vaccines but also to downright wrong conclusions, even flipping the results – in this case, making it appear that vaccines increase the risk of death.

This happened in August 2021, with a study out of Israel – a highly vaccinated country – showed 60% of those hospitalized with severe Covid were fully vaccinated, causing misinterpretation and raising questions about the continued value of vaccination.

Morris said he has also seen Simpson’s paradox when people look at the rate of Covid deaths before vaccines were rolled out in 2020 versus since then, or comparing countries with higher vaccination rates to countries with lower vaccination rates.

“It’s a lot more subtle, but the pandemic has provided a number of pure examples of it. So the bottom line with all of that is, we can’t accurately assess the effects of vaccines from simple summaries,” Morris said, however “seemingly intuitive” they may appear.

A more telling and accurate comparison is between the death rate per 100,000 among unvaccinated people compared to the death rate of vaccinated people, adjusted for age.

CDC data show that for the week of September 25, people age 12 and older who were unvaccinated had a death rate of 1.32 per 100,000. Those who were vaccinated (but without an updated, bivalent booster) had a death rate of 0.26 per 100,000. And those who were vaccinated and boosted had a death rate of 0.07 per 100,000.

Broken down further by age, the numbers are even starker: The death rate during that week for those in the oldest age group, 80 and above, was 14.16 per 100,000 for the unvaccinated, 3.69 for those who were vaccinated but had not received the bivalent booster, and 0.0 for those who were vaccinated and boosted.

Overall, the CDC estimates that for the whole month of September, among those 12 and older, there was an almost 15 times lower risk of dying from Covid-19 for the vaccinated and boosted compared to the unvaccinated.

Unfortunately, uptake of the booster is low: Only 13.5% of the US population 5 and older is vaccinated and has gotten the new updated (bivalent) booster. Among those 65 and older, that percentage is 34.2%.

It’s not to say that vaccines are entirely risk free. For example, in people – especially males – between the ages of 5 and 39, there were 224 verified cases of myocarditis or pericarditis, inflammation of the heart and lining, reported to the CDC after vaccination with an mRNA vaccine between December 14, 2020, and May 31, 2022. But that was out of almost 7 million vaccine doses administered.

A study examining those figures found myocarditis/pericarditis occurred within seven days approximately 0.0005% of the time after the first dose, 0.0033% of the time after the second dose of the primary series, and 0.002% after the first booster – but it varied by age and sex, and was much more common among 16- to-17-year-old males after a second shot or a booster.

According to a separate analysis of nearly 43 million people in England, the researchers found that for younger men, the Moderna vaccine in particular had the highest rates of post vaccine myocarditis – although this number was still very low, 97 per million people exposed (0.0097%) – leading some to suggest a different vaccine for that age group or a longer interval between vaccine doses.

Statistical optical illusions aside, the fact is, there are more so-called breakthrough cases among the vaccinated. They have always existed. Since December 2020, we have known these vaccines are not 100% effective at preventing severe illness and death, let alone infection. When vaccines were first introduced, their efficacy was estimated to be an astonishing 95% against severe illness and death. They even protected people at a very high rate against infection.

But the efficacy keeps ticking downward. Part of it is waning immunity: Over the course of several months, antibody levels fade away – that’s just how the body works – even though there is still some protection, thanks to B cells and T cells. Getting boosted – or catching Covid – can help increase antibody levels for a few months at least. Between those two options, it’s far safer and less disruptive to get a booster than to risk illness.

Meanwhile, new variants keep cropping up, and they are increasingly able to evade our immune system. Unlike earlier variants, including the highly transmissible Delta variant, descendants of the Omicron lineage are escape artists.

“The emergence of Omicron at the end of 2021 was a game changer, as Omicron and its subsequent subvariants demonstrated strong immune evasion properties, with mutations in the spike protein and especially the [receptor binding domain] that reduced the neutralizing ability of the vaccine-induced antibodies,” Morris noted. The result is a great reduction in vaccine efficacy against infection, as well as against severe and fatal disease.

This actually means it’s more important to get boosted, especially if you are in a high-risk category, and as the weather gets colder and we gather indoors to spend time together.

The newest booster – the bivalent booster – is designed to protect against the original SARS-CoV-2 virus and against the more recent Omicron subvariants, although how much and for how long is still unknown.

Covid cases, and deaths have slowed down in recent months, but those numbers are trending up like they’ve done during the holidays in previous pandemic years. For the week of December 7, weekly new cases topped 65,000 and Covid claimed the lives of almost 3,000 people. Both represent an increase of around 50% from the week before, according to CDC data.

All of this is happening at a time when hospitals are already full of patients sick with the flu and RSV.

I know we’re all tired of hearing that we need to roll up our sleeves and get yet another Covid-19 booster.

But remember, many of us get the flu shot every year: We don’t assume we are protected from a flu vaccine a year ago. We get the shot even in seasons when the flu vaccine is much less effective than the Covid vaccine (the latest one appears to be a good match). We don’t call it a booster – it’s just the annual flu vaccine. And we don’t track the rate of so-called breakthrough flu infections; unlike Covid, we don’t routinely test people for flu unless they are demonstrably sick, so we have no way of knowing how many people, vaccinated or not, are infected and asymptomatic or mildly ill.

For some diseases, like measles, a single vaccine or a previous infection provides us with a near lifetime of protection. Even though we hoped for a one-and-done scenario when the Covid vaccines rolled out two years ago, the virus didn’t lend itself to that. Newer vaccines are being studied that could offer far more durable protection.

Analyzing all of this data without falling into the trap of a base rate fallacy or Simpson’s paradox isn’t easy, as you can see. And it is also clear the overall effectiveness of the vaccines have waned over time and with new variants.

However, two years later, a more thorough statistical analysis of vaccine effectiveness shows they are still cause for celebration.

Read original article here

NASA successfully completes vital Artemis 1 rocket fuel test

The next Artemis 1 launch attempt might take place as soon as next week, seeing as NASA has met all the objectives it set out to do to consider its rocket’s fuel test a success. NASA had to test adding super-cooled fuel to the Space Launch System’s tanks to confirm the repairs it made after it scrubbed the mission’s second launch attempt in late August. The ground team at Kennedy Space Center spotted a persistent hydrogen leak affecting one of the fuel lines on the SLS at the time and tried to fix it the day of three times. In the end, the team was unsuccessful and decided to postpone the mission.

The team determined a few days later that the leak was triggered when the SLS rocket’s core booster tank went through a brief overpressurization. To prevent the same incident from happening, the team adjusted procedures for filling the rocket’s tank with propellants, and it involves transitioning temperatures and pressures more slowly to prevent rapid changes that could cause leakage. The team’s engineers also replaced the rocket’s liquid hydrogen seals after discovering a small indentation in one of them that may have contributed to the leak. 

While the engineers encountered another hydrogen leak during the fuel test, their troubleshooting efforts worked this time around and got the leak to “within allowable rates.” That allowed them to conduct the pre-pressurization test, which brought up the liquid hydrogen tank’s pressure level to match what it would experience just before an actual launch. 

Artemis 1 launch director Charlie Blackwell-Thompson said the test went “really well” and that the team was able to accomplish all the objectives it set out to do. NASA will now evaluate data from the test before deciding if it can schedule another launch for the mission on its target date of September 27th.

All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission. All prices are correct at the time of publishing.



Read original article here

Zombie cells central to the quest for active, vital old age

This microscope photo provided by the Mayo Clinic in August shows senescent myoblast cells. Senescent cells resist apoptosis, or programmed cell death, and characteristically get big and flat, with enlarged nuclei. (Dr. Xu Zhang, Mayo Clinic via Associated Press)

Estimated read time: 9-10 minutes

CINCINNATI — In an unfinished part of his basement, 95-year-old Richard Soller zips around a makeshift track encircling boxes full of medals he’s won for track and field and long-distance running.

Without a hint of breathlessness, he says: “I can put in miles down here.”

Steps away is an expensive leather recliner he bought when he retired from Procter and Gamble with visions of relaxing into old age. He proudly proclaims he’s never used it; he’s been too busy training for competitions, such as the National Senior Games.

Soller, who lives near Cincinnati, has achieved an enviable goal chased by humans since ancient times: Staying healthy and active in late life. It’s a goal that eludes so many that growing old is often associated with getting frail and sick. But scientists are trying to change that — and tackle one of humanity’s biggest challenges — through a little known but flourishing field of aging research called cellular senescence.

It’s built upon the idea that cells eventually stop dividing and enter a “senescent” state in response to various forms of damage. The body removes most of them. But others linger like zombies. They aren’t dead. But as the Mayo Clinic’s Nathan LeBrasseur puts it, they can harm nearby cells like moldy fruit corrupting a fruit bowl. They accumulate in older bodies, which mounting evidence links to an array of age-related conditions such as dementia, cardiovascular disease and osteoporosis.

But scientists wonder: Can the zombie cell buildup be stopped?

“The ability to understand aging — and the potential to intervene in the fundamental biology of aging — is truly the greatest opportunity we have had, maybe in history, to transform human health,” LeBrasseur says. Extending the span of healthy years impacts “quality of life, public health, socioeconomics, the whole shebang.”

With the number of people 65 or older expected to double globally by 2050, cellular senescence is “a very hot topic,” says Viviana Perez Montes of the National Institutes of Health. According to an Associated Press analysis of an NIH research database, there have been around 11,500 total projects involving cellular senescence since 1985, far more in recent years.

Richard Soller, 95, runs in the 200 meter race for men over 85 years old at the National Senior Games on May 16, in Miramar, Fla. After a torn hamstring stopped him from running track in high school, he fell into an unhealthy lifestyle in early adulthood, smoking two packs of cigarettes a day. But he and his wife Jean quit cold turkey when their daughter Mary came along. (Photo: Marta Lavandier, Associated Press)

About 100 companies, plus academic teams, are exploring drugs to target senescent cells. And research offers tantalizing clues that people may be able to help tame senescence themselves using the strategy favored by Soller: exercise.

Although no one thinks senescence holds the key to super long life, Tufts University researcher Christopher Wiley hopes for a day when fewer people suffer fates like his late grandfather, who had Alzheimer’s and stared back at him as if he were a stranger.

“I’m not looking for the fountain of youth,” Wiley says. “I’m looking for the fountain of not being sick when I’m older.”

Mortal cells

Leonard Hayflick, the scientist who discovered cellular senescence in 1960, is himself vital at 94. He’s a professor of anatomy at the University of California, San Francisco, and continues to write, present and speak on the topic.

At his seaside home in Sonoma County, he leafs through a binder filled with his research, including two early papers that have been cited an astonishing number of times by other researchers. Before him on the living room table are numerous copies of his seminal book, “How and Why We Age,” in various languages.

This scientific renown didn’t come easily. He discovered cellular senescence by accident, cultivating human fetal cells for a project on cancer biology and noticing they stopped dividing after about 50 population doublings. This wasn’t a big surprise; cell cultures often failed because of things like contamination. What was surprising was that others also stopped dividing at the same point. The phenomenon was later called “the Hayflick limit.”

The finding, Hayflick says, challenged “60-year-old dogma” that normal human cells could replicate forever. A paper he authored with colleague Paul Moorhead was rejected by a prominent scientific journal, and Hayflick faced a decade of ridicule after it was published in Experimental Cell Research in 1961.

“It followed the usual pattern of major discoveries in science, where the discoverer is first ridiculed and then somebody says, ‘Well, maybe it works’ … then it becomes accepted to some extent, then becomes more widely accepted.”

At this point, he says, “the field that I discovered has skyrocketed to an extent that’s beyond my ability to keep up with it.”

Jane Kaiser of Michigan, competes in the shot put during the National Senior Games, May 16 in Miramar, Fla. (Photo: Marta Lavandier, Associated Press)

Zombie buildup

Scientists are careful to note that cell senescence can be useful. It likely evolved at least in part to suppress the development of cancer by limiting the capacity of cells to keep dividing. It happens throughout our lives, triggered by things like DNA damage and the shortening of telomeres, structures that cap and protect the ends of chromosomes. Senescent cells play a role in wound healing, embryonic development and childbirth.

Problems can arise when they build up.

“When you’re young, your immune system is able to recognize these senescent cells and eliminate them,” says Perez, who studies cell biology and aging. “But when we start getting old … the activity of our immune system also gets diminished, so we’re losing the capacity to eliminate them.”


I’m not looking for the fountain of youth. I’m looking for the fountain of not being sick when I’m older.”

–Christopher Wiley, Tufts University


Senescent cells resist apoptosis, or programmed cell death, and characteristically get big and flat, with enlarged nuclei. They release a blend of molecules, some of which can trigger inflammation and harm other cells — and paradoxically can also stimulate the growth of malignant cells and fuel cancer, LeBrasseur says.

Scientists link some disorders to buildups of senescent cells in certain spots. For example, research suggests certain senescent cells that accumulate in lungs exposed to cigarette smoke may contribute substantially to airway inflammation in COPD.

The idea that one process could be at the root of numerous diseases is powerful to many scientists.

It inspired Dr. James Kirkland to move on from geriatric medicine. “I got tired of prescribing better wheelchairs and incontinence devices,” says Kirkland, a professor of medicine at Mayo considered a pioneer of the senescence renaissance. “I wanted to do something more fundamental that could alleviate the suffering that I saw.”

Drug targets

That quest leads him and others to develop medicines.

Experimental drugs designed to selectively clear senescent cells have been dubbed “senolytics,” and Mayo holds patents on some. In mice, they’ve been shown to be effective at delaying, preventing or easing several age-related disorders.

Possible benefits for people are just emerging. Kirkland, LeBrasseur and colleagues did a pilot study providing initial evidence that patients with a serious lung disease might be helped by pairing a chemotherapy drug with a plant pigment. Another pilot study found the same combination reduced the burden of senescent cells in the fat tissue of people with diabetic kidney disease.


Do as much as you can. That should be the goal for anyone to stay healthy.

–Richard Soller


At least a dozen clinical trials with senolytics are now testing things like whether they can help control Alzheimer’s progression, improve joint health in osteoarthritis and improve skeletal health. Some teams are trying to develop “senomorphics” that can suppress detrimental effects of molecules emitted by senescent cells. And a Japanese team has tested a vaccine on mice specific to a protein found in senescent cells, allowing for their targeted elimination.

Scientists say serious work to improve human health could also bring fringe benefits — like reducing skin wrinkling.

“I tell my lab that if we find a drug that clears the bad senescent cells and not the good ones and we cure Parkinson’s disease and Alzheimer’s and osteoporosis and macular degeneration, it would be wonderful,” says Judith Campisi, a biogerontology expert at the Buck Institute for Research on Aging. “But if we cure wrinkles, we’ll be rich, and I’ll never have to write another grant.”

Amid the buzz, some companies market dietary supplements as senolytics. But researchers warn they haven’t been shown to work or proven safe.

And there’s still much to learn about clinical trial drugs.

“We know that senolytics work pretty well in mice,” Wiley says. “We’re still really figuring out the basics with people.”

‘Most promising tool’

Today, LeBrasseur, who directs a center on aging at Mayo, says exercise is “the most promising tool that we have” for good functioning in late life, and its power extends to our cells.

Research suggests it counters the buildup of senescent ones, helping the immune system clear them and counteracting the molecular damage that can spark the senescence process.

A study LeBrasseur led last year provided the first evidence in humans that exercise can significantly reduce indicators, found in the bloodstream, of the burden of senescent cells in the body. After a 12-week aerobics, resistance and balance training program, researchers found that older adults had lowered indicators of senescence and better muscle strength, physical function and reported health. A recently-published research review collects even more evidence — in animals and humans — for exercise as a senescence-targeting therapy.

While such studies aren’t well-known outside scientific circles, many older adults intuitively equate exercise with youthfulness.

Rancher Mike Gale, 81, installed a track and field throwing circle on his sprawling property in Petaluma, California, so he and some friends could practice throwing the discus and other equipment. Against a backdrop of rolling green hills, they twist, step, throw and retrieve over and over again.

“I’d like to be competing in my 90s,” Gale says. “Why not?”

Phil Milliman of Washington State, competes in the pole vault during the National Senior Games, May 16 in Miramar, Fla. (Photo: Marta Lavandier, Associated Press)

Soller asked himself a similar question long ago.

After a torn hamstring stopped him from running track in high school, he fell into an unhealthy lifestyle in early adulthood, smoking two packs of cigarettes a day. But he and his wife Jean quit cold turkey when their daughter Mary came along.

He started running again just before turning 50, and since then has run in races across the U.S., including two marathons, and participated in decades of Senior Games competitions. In May, Soller joined 12,000 like-minded athletes in Florida for the latest national games in the Fort Lauderdale area — winning five medals to add to his collection of 1,500 prizes.

His daughter filmed his first-place finish in the 200-meter dash from the stands, cheering: “Go, Dad, go!”

Soller says exercise keeps him fit enough to handle what comes his way — including an Alzheimer’s diagnosis for his wife of 62 years. They sometimes stroll neighborhood streets together, holding hands.

“Do as much as you can,” he says. “That should be the goal for anyone to stay healthy.”

Contributing: Angie Wang

Photos

Most recent Science stories

More stories you may be interested in

Read original article here

Zombie cells central to the quest for active, vital old age

In an unfinished part of his basement, 95-year-old Richard Soller zips around a makeshift track encircling boxes full of medals he’s won for track and field and long-distance running.

Without a hint of breathlessness, he says: “I can put in miles down here.”

Steps away is an expensive leather recliner he bought when he retired from Procter & Gamble with visions of relaxing into old age. He proudly proclaims he’s never used it; he’s been too busy training for competitions, such as the National Senior Games.

Soller, who lives near Cincinnati, has achieved an enviable goal chased by humans since ancient times: Staying healthy and active in late life. It’s a goal that eludes so many that growing old is often associated with getting frail and sick. But scientists are trying to change that — and tackle one of humanity’s biggest challenges — through a little known but flourishing field of aging research called cellular senescence.

It’s built upon the idea that cells eventually stop dividing and enter a “senescent” state in response to various forms of damage. The body removes most of them. But others linger like zombies. They aren’t dead. But as the Mayo Clinic’s Nathan LeBrasseur puts it, they can harm nearby cells like moldy fruit corrupting a fruit bowl. They accumulate in older bodies, which mounting evidence links to an array of age-related conditions such as dementia, cardiovascular disease and osteoporosis.

But scientists wonder: Can the zombie cell buildup be stopped?

“The ability to understand aging – and the potential to intervene in the fundamental biology of aging – is truly the greatest opportunity we have had, maybe in history, to transform human health,” LeBrasseur says. Extending the span of healthy years impacts “quality of life, public health, socioeconomics, the whole shebang.”

With the number of people 65 or older expected to double globally by 2050, cellular senescence is “a very hot topic,” says Viviana Perez Montes of the National Institutes of Health. According to an Associated Press analysis of an NIH research database, there have been around 11,500 total projects involving cellular senescence since 1985, far more in recent years.

About 100 companies, plus academic teams, are exploring drugs to target senescent cells. And research offers tantalizing clues that people may be able to help tame senescence themselves using the strategy favored by Soller: exercise.

Although no one thinks senescence holds the key to super long life, Tufts University researcher Christopher Wiley hopes for a day when fewer people suffer fates like his late grandfather, who had Alzheimer’s and stared back at him as if he were a stranger.

“I’m not looking for the fountain of youth,” Wiley says. “I’m looking for the fountain of not being sick when I’m older.”

MORTAL CELLS

Leonard Hayflick, the scientist who discovered cellular senescence in 1960, is himself vital at 94. He’s a professor of anatomy at the University of California, San Francisco, and continues to write, present and speak on the topic.

At his seaside home in Sonoma County, he leafs through a binder filled with his research, including two early papers that have been cited an astonishing number of times by other researchers. Before him on the living room table are numerous copies of his seminal book, “How and Why We Age,” in various languages.

This scientific renown didn’t come easily. He discovered cellular senescence by accident, cultivating human fetal cells for a project on cancer biology and noticing they stopped dividing after about 50 population doublings. This wasn’t a big surprise; cell cultures often failed because of things like contamination. What was surprising was that others also stopped dividing at the same point. The phenomenon was later called “the Hayflick limit.”

The finding, Hayflick says, challenged “60-year-old dogma” that normal human cells could replicate forever. A paper he authored with colleague Paul Moorhead was rejected by a prominent scientific journal, and Hayflick faced a decade of ridicule after it was published in Experimental Cell Research in 1961.

“It followed the usual pattern of major discoveries in science, where the discoverer is first ridiculed and then somebody says, ‘Well, maybe it works’ … then it becomes accepted to some extent, then becomes more widely accepted.”

At this point, he says, “the field that I discovered has skyrocketed to an extent that’s beyond my ability to keep up with it.”

ZOMBIE BUILDUP

Scientists are careful to note that cell senescence can be useful. It likely evolved at least in part to suppress the development of cancer by limiting the capacity of cells to keep dividing. It happens throughout our lives, triggered by things like DNA damage and the shortening of telomeres, structures that cap and protect the ends of chromosomes. Senescent cells play a role in wound healing, embryonic development and childbirth.

Problems can arise when they build up.

“When you’re young, your immune system is able to recognize these senescent cells and eliminate them,” says Perez, who studies cell biology and aging. “But when we start getting old … the activity of our immune system also gets diminished, so we’re losing the capacity to eliminate them.”

Senescent cells resist apoptosis, or programmed cell death, and characteristically get big and flat, with enlarged nuclei. They release a blend of molecules, some of which can trigger inflammation and harm other cells — and paradoxically can also stimulate the growth of malignant cells and fuel cancer, LeBrasseur says.

Scientists link some disorders to buildups of senescent cells in certain spots. For example, research suggests certain senescent cells that accumulate in lungs exposed to cigarette smoke may contribute substantially to airway inflammation in COPD.

The idea that one process could be at the root of numerous diseases is powerful to many scientists.

It inspired Dr. James Kirkland to move on from geriatric medicine. “I got tired of prescribing better wheelchairs and incontinence devices,” says Kirkland, a professor of medicine at Mayo considered a pioneer of the senescence renaissance. “I wanted to do something more fundamental that could alleviate the suffering that I saw.”

DRUG TARGETS

That quest leads him and others to develop medicines.

Experimental drugs designed to selectively clear senescent cells have been dubbed “senolytics,” and Mayo holds patents on some. In mice, they’ve been shown to be effective at delaying, preventing or easing several age-related disorders.

Possible benefits for people are just emerging. Kirkland, LeBrasseur and colleagues did a pilot study providing initial evidence that patients with a serious lung disease might be helped by pairing a chemotherapy drug with a plant pigment. Another pilot study found the same combination reduced the burden of senescent cells in the fat tissue of people with diabetic kidney disease.

At least a dozen clinical trials with senolytics are now testing things like whether they can help control Alzheimer’s progression, improve joint health in osteoarthritis and improve skeletal health. Some teams are trying to develop “senomorphics” that can suppress detrimental effects of molecules emitted by senescent cells. And a Japanese team has tested a vaccine on mice specific to a protein found in senescent cells, allowing for their targeted elimination.

Scientists say serious work to improve human health could also bring fringe benefits – like reducing skin wrinkling.

“I tell my lab that if we find a drug that clears the bad senescent cells and not the good ones and we cure Parkinson’s disease and Alzheimer’s and osteoporosis and macular degeneration, it would be wonderful,” says Judith Campisi, a biogerontology expert at the Buck Institute for Research on Aging. “But if we cure wrinkles, we’ll be rich, and I’ll never have to write another grant.”

Amid the buzz, some companies market dietary supplements as senolytics. But researchers warn they haven’t been shown to work or proven safe.

And there’s still much to learn about clinical trial drugs.

“We know that senolytics work pretty well in mice,” Wiley says. “We’re still really figuring out the basics with people.”

‘MOST PROMISING TOOL’

Today, LeBrasseur, who directs a center on aging at Mayo, says exercise is “the most promising tool that we have” for good functioning in late life, and its power extends to our cells.

Research suggests it counters the buildup of senescent ones, helping the immune system clear them and counteracting the molecular damage that can spark the senescence process.

A study LeBrasseur led last year provided the first evidence in humans that exercise can significantly reduce indicators, found in the bloodstream, of the burden of senescent cells in the body. After a 12-week aerobics, resistance and balance training program, researchers found that older adults had lowered indicators of senescence and better muscle strength, physical function and reported health. A recently-published research review collects even more evidence — in animals and humans — for exercise as a senescence-targeting therapy.

While such studies aren’t well-known outside scientific circles, many older adults intuitively equate exercise with youthfulness.

Rancher Mike Gale, 81, installed a track and field throwing circle on his sprawling property in Petaluma, California, so he and some friends could practice throwing the discus and other equipment. Against a backdrop of rolling green hills, they twist, step, throw and retrieve over and over again.

“I’d like to be competing in my 90s,” Gale says. “Why not?”

Soller asked himself a similar question long ago.

After a torn hamstring stopped him from running track in high school, he fell into an unhealthy lifestyle in early adulthood, smoking two packs of cigarettes a day. But he and his wife Jean quit cold turkey when their daughter Mary came along.

He started running again just before turning 50, and since then has run in races across the U.S., including two marathons, and participated in decades of Senior Games competitions. In May, Soller joined 12,000 like-minded athletes in Florida for the latest national games in the Fort Lauderdale area – winning five medals to add to his collection of 1,500 prizes.

His daughter filmed his first-place finish in the 200-meter dash from the stands, cheering: “Go, Dad, go!”

Soller says exercise keeps him fit enough to handle what comes his way – including an Alzheimer’s diagnosis for his wife of 62 years. They sometimes stroll neighborhood streets together, holding hands.

“Do as much as you can,” he says. “That should be the goal for anyone to stay healthy.”

___

Video journalist Angie Wang contributed to this story.

——

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Read original article here